InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,064.20
(
0.91%
)
US TECH 100
17,170.00
(
1.83%
)
Dow Jones
38,225.66
(
0.85%
)
Brent Oil
83.63
(
0.11%
)
Bitcoin
58,817.06
(
0.99%
)
Post# of 146201
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

loanranger

Send PM Follow Ignore
Followers 209
Posts 32113
Boards Moderated 1
Alias Born 06/30/2009

loanranger

Member Level

Re: drkazmd65 post# 146163

Monday, 01/29/2024 11:28:43 AM

Monday, January 29, 2024 11:28:43 AM

Post# of 146201
So if I follow this PR the dosages of NV-387 administered to 36 healthy patients did not make them sick (specifically "No adverse events were reported in any of the multiple ascending dose cohorts").

Later we're told "In contrast, most known antiviral drugs have significant dose-limiting toxicities."
The clear import of that statement is that NV-387 DOES NOT have significant dose-limiting toxicities.
Can you point me to the language in the pr and the data from the current trial that supports that conclusion?

TIA.

No matter what it is or who commenced it, I'm against it!
....Groucho

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NNVC News
More NNVC News
InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!